{"id":9934,"date":"2018-03-25T05:00:39","date_gmt":"2018-03-25T09:00:39","guid":{"rendered":"https:\/\/medicarereport.org\/?p=9934"},"modified":"2018-03-23T11:50:24","modified_gmt":"2018-03-23T15:50:24","slug":"340b-is-a-well-intentioned-drug-discount-program-gone-awry","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=9934","title":{"rendered":"340B is a well-intentioned drug discount program gone awry"},"content":{"rendered":"<p>(By Elsa Pearson and Austin Frankt for ST<em>A<\/em>T)<\/p>\n<p class=\"big-cap-wrap danger-zone\"><span class=\"big-cap\">Hospitals and clinics serving high-risk, high-need patient populations, including low-income and uninsured individuals, have long benefitted from a\u00a0<a href=\"https:\/\/www.statnews.com\/2017\/11\/06\/340b-drug-discounts-fight\/\">federal program<\/a>\u00a0that allows them to buy medicines from drug makers at a steep discount. <a href=\"https:\/\/www.statnews.com\/2018\/03\/22\/340b-drug-discount-program-gone-awry\/?_hsenc=p2ANqtz-9k9Xw-8kZP-Sj8Lsm4kV6uIlMiUcnSBndNtdFhlP6M-iRU9ApRGF_6T-d2bS_sEaU2ahFJFQ_eylUNNx-zk3itSfyT0Q&amp;_hsmi=61586167\">Continue reading article here&#8230;<\/a><\/span><\/p>\n<p class=\"big-cap-wrap danger-zone\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Elsa Pearson and Austin Frankt for STAT) Hospitals and clinics serving high-risk, high-need patient populations, including low-income and uninsured<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,15],"tags":[],"class_list":["post-9934","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9934"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9934\/revisions"}],"predecessor-version":[{"id":9935,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9934\/revisions\/9935"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}